Koch R, Burton B, Hoganson G, Peterson R, Rhead W, Rouse B, Scott R, Wolff J, Stern A M, Guttler F, Nelson M, de la Cruz F, Coldwell J, Erbe R, Geraghty M T, Shear C, Thomas J, Azen C
Children's Hospital Los Angeles, Department of Pediatrics, Keck School of Medicine, University of Southern California, 90027, USA.
J Inherit Metab Dis. 2002 Sep;25(5):333-46. doi: 10.1023/a:1020158631102.
During 1967-1983, the Maternal and Child Health Division of the Public Health Services funded a collaborative study of 211 newborn infants identified on newborn screening as having phenylketonuria (PKU). Subsequently, financial support was provided by the National Institute of Child Health and Human Development (NICHD). The infants were treated with a phenylalanine (Phe)-restricted diet to age 6 years and then randomized either to continue the diet or to discontinue dietary treatment altogether. One hundred and twenty-five of the 211 children were then followed until 10 years of age. In 1998, NICHD scheduled a Consensus Development Conference on Phenylketonuria and initiated a study to follow up the participants from the original Collaborative Study to evaluate their present medical, nutritional, psychological, and socioeconomic status. Fourteen of the original clinics (1967-1983) participated in the Follow-up Study effort. Each clinic director was provided with a list of PKU subjects who had completed the original study (1967-1983), and was asked to evaluate as many as possible using a uniform protocol and data collection forms. In a subset of cases, magnetic resonance imaging and spectroscopy (MRI/MRS) were performed to study brain Phe concentrations. The medical evaluations revealed that the subjects who maintained a phenylalanine-restricted diet reported fewer problems than the diet discontinuers, who had an increased rate of eczema, asthma, mental disorders, headache, hyperactivity and hypoactivity. Psychological data showed that lower intellectual and achievement test scores were associated with dietary discontinuation and with higher childhood and adult blood Phe concentrations. Abnormal MRI results were associated with higher brain Phe concentrations. Early dietary discontinuation for subjects with PKU is associated with poorer outcomes not only in intellectual ability, but also in achievement test scores and increased rates of medical and behavioural problems.
1967年至1983年期间,公共卫生服务部母婴健康司资助了一项针对211名新生儿的合作研究,这些新生儿在新生儿筛查中被确定患有苯丙酮尿症(PKU)。随后,国家儿童健康与人类发展研究所(NICHD)提供了资金支持。这些婴儿接受了低苯丙氨酸(Phe)饮食治疗,直至6岁,然后随机分为继续饮食治疗组或完全停止饮食治疗组。211名儿童中的125名随后被随访至10岁。1998年,NICHD安排了一次关于苯丙酮尿症的共识发展会议,并启动了一项研究,对原始合作研究的参与者进行随访,以评估他们目前的医疗、营养、心理和社会经济状况。原始的14家诊所(1967年至1983年)参与了随访研究工作。每个诊所主任都收到了一份完成原始研究(1967年至1983年)的PKU受试者名单,并被要求使用统一的方案和数据收集表格对尽可能多的受试者进行评估。在一部分病例中,进行了磁共振成像和波谱分析(MRI/MRS)以研究脑苯丙氨酸浓度。医学评估显示,坚持低苯丙氨酸饮食的受试者报告的问题少于停止饮食治疗的受试者,后者患湿疹、哮喘、精神障碍、头痛、多动和活动过少的比率有所增加。心理数据表明,较低的智力和成就测试分数与饮食中断以及儿童期和成年期较高的血液苯丙氨酸浓度有关。异常的MRI结果与较高的脑苯丙氨酸浓度有关。PKU受试者过早停止饮食不仅与智力能力较差有关,还与成就测试分数较低以及医疗和行为问题发生率增加有关。